About Clinical Research Hamburg
Clinical Research Hamburg is a company based in Hamburg (Germany) founded in 2004 by Axel Holst was acquired by Velocity Clinical Research in July 2022.. Clinical Research Hamburg offers products and services including Clinical Trials and Patient Recruitment. Clinical Research Hamburg operates in a competitive market with competitors including PPD, Cambrian BioPharma, Medicus Pharma, H.U. Group Holdings and DM Clinical, among others.
- Headquarter Hamburg, Germany
- Founders Axel Holst
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Velocity Clinical Research Germany Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Velocity Clinical Research
(Jul 27, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Clinical Research Hamburg
Clinical Research Hamburg offers a comprehensive portfolio of products and services, including Clinical Trials and Patient Recruitment. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Conducts phases 2-4 trials for medical research
Facilitates participant enrollment for clinical studies
Funding Insights of Clinical Research Hamburg
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Clinical Research Hamburg
Clinical Research Hamburg has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Velocity Clinical Research. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of site management and patient recruitment services
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Clinical Research Hamburg
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Clinical Research Hamburg
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Clinical Research Hamburg Comparisons
Competitors of Clinical Research Hamburg
Clinical Research Hamburg operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PPD, Cambrian BioPharma, Medicus Pharma, H.U. Group Holdings and DM Clinical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
CRO providing diversified clinical development services
|
|
| domain | founded_year | HQ Location |
Medicines and therapies are developed for healthcare applications.
|
|
| domain | founded_year | HQ Location |
Clinical stage, multi-strategy holding company focused on investing in and accelerating novel therapies in the biotechnology and life sciences industry
|
|
| domain | founded_year | HQ Location |
Provider of clinical testing, diagnostics, and healthcare services. This entity offers a range of services encompassing laboratory testing and related services, in-vitro diagnostics, healthcare-related services, and research and development. Their activities include supporting research in clinical laboratory medicine, fostering technological advancements, and contributing to the overall progress of medical science and healthcare technology. They also engage in intellectual property activities and have initiatives addressing public health concerns.
|
|
| domain | founded_year | HQ Location |
Conducts Phase I-IV clinical trials connecting patients with physicians for medical research.
|
|
| domain | founded_year | HQ Location |
Serves as a contract research organization focused on drug clinical trials.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Clinical Research Hamburg
Frequently Asked Questions about Clinical Research Hamburg
When was Clinical Research Hamburg founded?
Clinical Research Hamburg was founded in 2004.
Where is Clinical Research Hamburg located?
Clinical Research Hamburg is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.
What does Clinical Research Hamburg do?
Clinical Research Hamburg was established in 2004 by founder Axel Holst in Hamburg, Germany. Services in clinical research are provided for phases II, III, and IV across multiple indications in human medicine. Operations focus on supporting pharmaceutical and medical research needs within the healthcare sector. The company is based in Germany and serves clients through its domain crh-hamburg.de, emphasizing structured trial management and data handling.
Who are the top competitors of Clinical Research Hamburg?
Clinical Research Hamburg's top competitors include PPD, Cambrian BioPharma and Medicus Pharma.
What products or services does Clinical Research Hamburg offer?
Clinical Research Hamburg offers Clinical Trials and Patient Recruitment.
Who are Clinical Research Hamburg's investors?
Clinical Research Hamburg has 1 investor. Key investors include Velocity Clinical Research.